YAHOO POLL: Do you think getting Botox is safe?
There are a growing number of young Singaporeans (in their 20s and 30s) who are getting injectables to improve their facial appearances, according to a recent report by The Straits Times (ST).
Despite the risks of such cosmetic enhancements and the unnatural appearance seen in Hollywood celebrities who have undergone such treatments, dermatologists and aestheticians have noted an increase of between 10 and 20 per cent in the number of young people in Singapore who use injectables for cosmetic reasons since 2020.
Aside from incorrect techniques or over-treatment, some of the side effects include a loss of muscle and decrease in their strength, reduced effectiveness over time, and even addiction or over-reliance on injectables.
These treatments aren't permanent and injections are administered quarterly or yearly, with the frequency depending on the kind of treatment sought.
Other polls
YAHOO POLL: Would you date someone shorter than you?
YAHOO POLL: Have you completed Malaysia's VEP requirement?
YAHOO POLL: Are exclusive concerts the way to go for Singapore tourism right now?
For younger patients, Botox isn't about melting wrinkles and frown lines, or to 'freeze' the ageing process. They're also using it to tweak their appearances.
A patient who underwent the treatment told ST that after getting the Botox and fillers, "the results were so good that I wanted to try more procedures".
So, we want to hear from you – Do you think that getting Botox is safe?
Related:
I'm in my 40s. Is it too late to try Botox?
Cosmetic procedures are more accessible – and less taboo – than ever before. Younger women are going along for the ride.
Study finds deceptively simple solution to attractiveness beats botox
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
44 minutes ago
- Yahoo
Specialised Therapeutics Expands Partnership with Incyte to Include Two Additional Therapies for Hard-to-Treat Conditions
SINGAPORE, June 12, 2025 /PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics (ST) is pleased to announce the expansion of its existing supply and distribution agreement with Incyte Biosciences International Sàrl, the Swiss-based affiliate of Incyte (NASDAQ:INCY), to launch and distribute two additional medicines from its oncology portfolio in Australia, New Zealand and Singapore, with an option to add further countries in the Asia-Pacific region. The expanded agreement will see new therapies axatilimab (registered as Niktimvo® in the United States) and retifanlimab (registered as Zynyz® in the U.S. and European Union) added to the current partnered portfolio of Minjuvi® (tafasitamab) and Pemazyre® (pemigatinib). Under the terms of the expanded agreement, Incyte will be responsible for the development, manufacture and supply of both axatilimab and retifanlimab to the region, while ST will have responsibility for regulatory, distribution and local marketing and medical affairs related activities. ST Chief Executive Officer, Mr Carlo Montagner, welcomed the expansion of the partnership agreement with Incyte, a leading global biopharmaceutical company, and the opportunity to bring these important medicines to eligible patients in the local region. "Specialised Therapeutics has partnered with Incyte since 2021 and we are delighted to be extending this successful partnership," he said. "As part of our initial agreement, our teams have worked collaboratively to commercialise Minjuvi, which has been approved for use in Australia, and Pemazyre, which has been approved in Australia and Singapore, and we look forward to expanding the portfolio to help more patients with rare and hard-to-treat conditions." "The addition of axatilimab and retifanlimab to the partnership agreement with Incyte recognises our strong track record of working with local stakeholders to bring innovative medicines to patients where unmet medical needs persist, despite the availability of existing treatments," said Mr Montagner. "Our focus will be on seeking regulatory and reimbursement approval for all four medicines in the region, to ensure equitable access to these treatments are available for patients as soon as practicable." ST anticipates submitting axatilimab and retifanlimab for local regulatory and reimbursement approval in 2025. Incyte CEO, Mr Hervé Hoppenot said the expanded partnership agreement reflected the synergies between the two companies, with a shared goal of improving outcomes for patients with unmet medical needs. "We are pleased to extend our partnership with ST to include axatilimab and retifanlimab," he said. "ST has already demonstrated its ability to navigate complex regional regulatory pathways for Minjuvi and Pemazyre, and we look forward to continuing our work together to make these new therapies available for the oncology community in the Asia-Pacific region." Axatilimab is a first-in-class colony stimulating factor-1 receptor (CSF-1R)-blocking antibody. It was approved by the US Food and Drug Administration (FDA) in August 2024 as a treatment for adults and children with chronic graft-versus-host disease (GVHD) who have received at least two prior treatments (systemic therapy) and require additional treatment.1 Chronic GVHD usually occurs 3 months after a transplant - typically haematopoietic stem cell or bone marrow transplantation, but occasionally also solid organ transplants - where the donor cells ("graft") attack the graft recipient's cells ("host").2 Chronic GVHD can affect all organs, but commonly impacts the skin, mouth, eyes, lungs, stomach, bowel, and liver.2,3 The Phase II clinical trial for axatilimab involved 79 patients from 13 countries, including Australia and Singapore.4 Retifanlimab is an intravenous immune checkpoint (PD-1) inhibitor that has been approved in the US in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal canal (SCAC) and as a single agent for the treatment of adult patients with locally recurrent or metastatic SCAC with disease progression or intolerance to platinum-based chemotherapy.5 Retifanlimab is also approved in the US6 and Europe7 for the treatment of adults with metastatic or recurrent locally advanced Merkel cell carcinoma (MCC). MCC is a rare and aggressive type of skin cancer, that is often difficult to diagnose due to the lack of specific features to distinguish it from other common skin cancers.8 Australia has the highest incidence of MCC in the world.9 The pivotal Phase II clinical trial of retifanlimab in MCC enrolled 101 chemotherapy-naïve patients from 12 countries, including Australia.10 In addition to MCC, retifanlimab, in combination with chemotherapy, is currently being investigated as a potential therapeutic option in other hard-to-treat cancers, including metastatic non-small cell lung cancer (NSCLC). Ends. About Specialised Therapeutics Founded in 2007, Specialised Therapeutics is the region's largest independent specialty pharmaceutical company, providing new therapies and technologies to patients in Australia, New Zealand and across Southeast Asia. Headquartered in Singapore, ST partners with global pharmaceutical, biotech and diagnostic companies to bring novel healthcare opportunities to patients who are impacted by a range of diseases. ST has built a strong track record of success, navigating complex regulatory, reimbursement and commercialisation environments in its diverse regions. The ST mission is to provide specialty therapies where there is an unmet need. The company's broad therapeutic portfolio currently includes novel agents in oncology, haematology, CNS, neurology, endocrinology, ophthalmology and supportive care, although it is not confined to these areas. ST is a member of the World Orphan Drug Alliance (WODA). Additional information can be found at About axatilimab (Niktimvo®) Axatilimab-csfr (registered as Niktimvo® in the United States) is a first-in-class colony stimulating factor-1 receptor (CSF-1R)-blocking antibody approved for use in the US for the treatment of chronic graft-versus-host disease (GVHD) after failure of at least two prior lines of systemic therapy in adult and paediatric patients weighing at least 40 kg (88.2 lbs). In 2016, Syndax licensed exclusive worldwide rights to develop and commercialise axatilimab from UCB. In September 2021, Syndax and Incyte entered into an exclusive worldwide co-development and co-commercialisation license agreement for axatilimab in chronic GVHD and any future indications. Axatilimab is being studied in frontline combination trials in chronic GVHD – a Phase 2 combination trial with ruxolitinib (NCT06388564) and a Phase 3 combination trial with steroids (NCT06585774) are underway. Axatilimab is also being studied in an ongoing Phase 2 trial in patients with idiopathic pulmonary fibrosis (NCT06132256). Niktimvo is a trademark of other trademarks are the property of their respective owners. About retifanlimab (Zynyz®) Retifanlimab-dlwr (registered as Zynyz® in the United States and European Union) is a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), indicated in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal canal (SCAC) and as a single agent for the treatment of adult patients with locally recurrent or metastatic SCAC with disease progression or intolerance to platinum-based chemotherapy in the U.S. Zynyz is also indicated for the treatment of adult patients with metastatic or recurrent locally advanced Merkel cell carcinoma (MCC) in the US. This indication is approved under accelerated approval based on tumour response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials. Zynyz is marketed by Incyte in the US. In 2017, Incyte entered into an exclusive collaboration and license agreement with MacroGenics, Inc. for global rights to retifanlimab. Zynyz is a registered trademark of Incyte. References: US FDA. FDA approves axatilimab-csfr for chronic graft-versus-host disease, 14 Aug 2024. Available at: drugs/resources-information-approved-drugs/fda-approves-axatilimab-csfr-chronic-graft-versus-host-disease [Accessed Mar 2025]. The Australasian College of Dermatologists. A-Z of Skin: Graft Versus Host Disease, Nov 2020. Available at: [Accessed Mar 2025]. Leukaemia Foundation Australia. Factsheet: Graft versus host disease, 24 May 2024. Available at: [Accessed Mar 2025]. A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD) (AGAVE-201); NCT04710576. Available at: [Accessed Mar 2025]. FDA approves retifanlimab-dlwr with carboplatin and paclitaxel and as a single agent for squamous cell carcinoma of the anal canal. [Accessed May 2025] US FDA. FDA grants accelerated approval to retifanlimab-dlwr for metastatic or recurrent locally advanced Merkel cell carcinoma, 22 Mar 2023. Available at: [Accessed Mar 2025]. European Medicines Agency (EMA). Zynyz (retifanlimab): Marketing Authorisation in the European Union (EU), 19 Apr 2024. Available at: [Accessed Mar 2025]. NeuroEndocrine Cancer Australia. Merkel Cell Carcinoma: The Facts, 19 Nov 2023. Available at: [Accessed Mar 2025]. The Australasian College of Dermatologists. A-Z of Skin: Merkel cell carcinoma, Oct 2024. Available at: atoz/merkel-cell-carcinoma/ [Accessed Mar 2025]. Grignani G, et al. Updated Results From POD1UM-201: A Phase 2 Study of Retifanlimab in Patients With Advanced or Metastatic Merkel Cell Carcinoma. Presented at the European Society for Medical Oncology Congress 2023, Madrid, Spain; 20-24 October 2023. View original content to download multimedia: SOURCE Specialised Therapeutics Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Medical Spa Market Size worth $49.4 billion by 2030 with 15.13% CAGR - Exclusive Study by The Research Insights
CHICAGO, June 12, 2025 /PRNewswire/ -- The global medical spa market size is projected to be valued at USD 21.2 billion in 2024 and reach USD 49.4 billion by 2030, growing at a CAGR of 15.13% according to a new report by The Research Insights. The medical spa market has transformed beyond physical appearance enhancements to focus more on supporting complete well-being. More consumers today look for beauty solutions that merge inner health with traditional aesthetic treatments as equally important aspects. The convergence of wellness and holistic treatments within medical spa services has brought about a more comprehensive rejuvenating experience. The report runs an in-depth analysis of market trends, key players, and future opportunities. In general, the medical spa market growth of 15.13% comprises a range of service, age group, gender, service provider and geography which are expected to register strength during the coming years. For More Information and To Stay Updated on The Latest Developments in The Medical Spa Market Share, Download FREE Sample Pages: Market Overview and Growth Trajectory: Medical Spa Market Growth: According to an exhaustive report by The Research Insights, the Medical Spa Market is undergoing significant growth, driven the increasing number of medical spa customers prioritize sustainable practices and clean beauty products when making decisions about their self-care investments. This change demonstrates an enhanced understanding that personal wellness cannot be separated from planetary health. Medical spa clients demonstrate a rising demand for sustainable operations by preferring biodegradable treatment materials alongside recyclable packaging and energy-efficient devices. The medical spa industry stands to prosper as clean beauty establishes its place as a standard by combining outcome-focused treatments with ethical and eco-conscious principles which build trust and secure lasting customer dedication. Rising Demand for Non-Invasive Aesthetic Treatment in the Medical Spa Market: The medical spa market has experienced substantial growth because more people are seeking aesthetic procedures that do not involve surgery. Current consumers prefer aesthetic treatments which deliver visible outcomes while avoiding the risks and expenses of traditional surgery and its related downtime. Mainstream adoption of procedures like Botox alongside dermal fillers and non-surgical skin tightening reflects their popularity among people who aim for minimal enhancements or anti-aging effects. The impact of social media endures as influencers and celebrities publicly support aesthetic treatments and help normalize cosmetic self-care practices. Modern beauty standards are changing which leads to more individuals including both males and younger age groups seeking services from medical spas. The global medical spa market will experience sustained growth driven by non-invasive procedures as technology advances and market demand increases. For Detailed Market Insights, Visit: Partnerships with Dermatology Clinics and Wellness Centers: Strategic partnerships are becoming a critical strategy in the evolving medical spa market for service expansion and credibility building while drawing in wider customer groups. A significant trend in the industry includes medical spas working together with dermatology clinics and wellness centers. The partnership between medical spas and dermatology clinics is delivering comprehensive client experiences which focus on aesthetic enhancements alongside sustained skin health. Medical spas can deliver more sophisticated treatments under dermatologist supervision through partnerships that enable acne therapy options along with pigmentation correction and personalized anti-aging solutions. Through partnerships these spas obtain clinical validation for their services which ensures customers of the safety and effectiveness of their treatments. Dermatologists gain from spa amenities which provide enhanced comfort and satisfaction for patients along with added convenience and luxury. Medical spa market is growing quickly and competitive which makes these partnerships essential for differentiation and expansion while fulfilling the need for personalized self-care services. Facial Treatments Remain the Cornerstone of Growth in the Medical Spa Market: The medical spa market shows facial treatments as the dominant preference with the largest market share because of their flexible nature and rapid results with little downtime. Medical spa services such as hydrafacials and microdermabrasion along with laser skin resurfacing and anti-aging facials provide solutions for diverse skin problems including acne hyperpigmentation and fine lines. Facial treatments gain popularity through exposure on social media platforms and the widespread goal of achieving a youthful look that looks good on camera. Medical spas now offer advanced facial treatments that combine diagnostic tools and serums with non-invasive technologies to meet the rising demand for personalized skincare solutions. The combination of high repeat rates and multiple treatment modalities in one session enables facial treatments to both improve customer satisfaction and increase recurring revenue for providers. Facial treatments continue to function as a primary revenue engine while maintaining strategic importance in the developing medical spa landscape. Stay Updated on The Latest Medical Spa Market Trends: Geographical Insights: The medical spa market sees North America as its leader because of its robust healthcare system along with consumer awareness and dedication to personal grooming and wellness. A significant number of licensed medical spas offering advanced non-invasive treatments including Botox, laser therapy, and tailored facials exist in the United States. The medical spa market in Asia Pacific experiences the most rapid growth because of increased disposable income and urbanization along with higher acceptance of cosmetic procedures among its younger demographic. The European medical spa market merges wellness and medical aesthetics in balance while Germany, France, Italy, and the UK spearhead this initiative. Medical Spa Market Segmentation and Geographical Insights: Based on service, the medical spa market size is divided into facial treatment, body shaping & contouring, hair removal, scar revision, tattoo removal and other services. The facial treatment segment held the largest share of the medical spa market in 2024. Based on age group, the medical spa market share is divided into adolescent, adult and geriatric. The adult segment accounted for a larger share of the medical spa market in 2024. Based on gender, the medical spa market size is divided into male and female. The female segment held the largest share of the medical spa market in 2024. Based on service provider, the medical spa market share is divided into single ownership, group ownership, free-standing and medical practice associated spas. The single ownership segment accounted for a larger share of the medical spa market in 2024. The medical spa market is segmented into five major regions: North America, Europe, Asia Pacific, Central & South America and Middle East & Africa. Purchase Premium Copy of Global Medical Spa Market Size and Growth Report (2024-2030) at: Key Players and Competitive Landscape: The Medical Spa Market is characterized by the presence of several major players, including: Chic La Vie Med Spa Clinique La Prairie Kurotel-Longevity Medical Center and Spa Lanserhof The Orchard Wellness Resort Biovital Medspa LLC Allure Medspa Longevity Wellness Worldwide Serenity Medspa Vichy Celestins Spa Hotel Brenners Park-Hotel & Spa SHA Wellness Clinic Cocoona Centre Of Aesthetic Transformation Mezzatorre Hotel and Thermal SPA Aesthetics Medispa Lily's Medical Spa Lisse The DRx Clinic Westchase Medspa Chiva Som Mandarin Oriental Hotel Group Limited These companies are adopting strategies such as new product launches, joint ventures, and geographical expansion to maintain their competitive edge in the market. Global Medical Spa Market Recent Developments and Innovations: In December 2024, LaserAway, announced a strategic partnership with a global skincare brand to incorporate high-end skincare products into their treatment offerings. This collaboration allows LaserAway to offer a more comprehensive range of treatments, enhancing the overall experience for clients. In November 2023, SHA Wellness Clinic launched its first international outpost in Mexico next January. The opening will be the first step in the company's global expansion plans, followed by an Abu Dhabi location in 2025. In January 2023, Chiva Som introduced an online naturopathic and nutritional consultation program designed for children. This initiative aimed to provide specialized holistic health guidance for children, reflecting the commitment to complete wellbeing. For Region-Specific Market Data, Check Out Brief Sample Pages: Key Questions Addressed: What is the key opportunity in the medical spa market?Personalization and bundling of aesthetic treatments in subscription formats are gaining popularity, ensuring customer retention and recurring revenue. What is the expected market size for medical spa market by 2030? The expected market size for medical spa is USD 49.4 Billion in 2030. Which major service are included in medical spa?Major service includes facial treatment, body shaping & contouring, hair removal, scar revision, tattoo removal and other services. Which service provider segment for medical spa market has the potential to register the highest market share? Single ownership segment for medical spa market is expected to register highest market share of 37% in 2024. Who are the key players in medical spa market?The key players in the market are Chic La Vie Med Spa, Clinique La Prairie, Kurotel-Longevity Medical Center and Spa, Lanserhof, The Orchard Wellness Resort, Biovital Medspa LLC, Allure Medspa, Longevity Wellness Worldwide, Serenity Medspa, Vichy Celestins Spa Hotel, Brenners Park-Hotel & Spa, SHA Wellness Clinic, Cocoona Centre Of Aesthetic Transformation, Mezzatorre Hotel & Thermal SPA, Aesthetics Medispa, Lily's Medical Spa, Lisse, The DRx Clinic, Westchase Medspa, Chiva Som and Mandarin Oriental Hotel Group Limited. Conclusion: The medical spa market is experiencing transformative changes because clinical expertise and holistic wellness converge as consumers demand treatments that boost physical appearance while promoting total health. Facial treatments remain the primary source of income for medical spas because their wide-reaching skin benefits deliver quick results and easy accessibility for clients. Technology-enabled personalized skincare solutions which incorporate AI diagnostics and custom treatments are resulting in increased client loyalty and satisfaction. Despite continuing regulatory hurdles and competition along with expensive advanced equipment the medical spa industry remains resilient because of innovation and growing demand for minimally invasive procedures and comprehensive care approaches. The medical spa market continues to develop as a vibrant sector that successfully addresses today's consumers' needs for both beauty and health solutions while promoting mindful self-care which supports its long-term worldwide expansion. Need A Diverse Region or Sector? Customize Research to Suit Your Requirement: The report from The Research Insights, therefore, provides several stakeholders—including raw material & equipment suppliers, product manufacturers, service providers, and medical professionals—with valuable insights into how to successfully navigate this evolving market landscape and unlock new opportunities. With projected growth to US$ 49.4 billion by 2030, the Medical Spa Market represents a significant opportunity for raw material & equipment suppliers, product manufacturers, service providers, and medical professionals, investors, industry stakeholders, and others. By staying abreast of market trends, embracing innovation, and focusing on quality and performance, companies can position themselves for success in this dynamic and evolving market landscape. Check out more related studies published by The Research Insights: U.S. Medical Spa Management Software Market - The U.S. medical spa management software market is poised for significant growth, with an estimated value of USD 118.1 million in 2023. As the industry continues to expand at a CAGR of 13.6% from 2024 to 2030, it's clear that these facilities are becoming increasingly popular due to their unique blend of wellness and beauty services. By offering a wide range of cosmetic treatments and procedures in a relaxing spa-like environment, medical spas have captured the hearts (and wallets) of consumers seeking a more holistic approach to their self-care routines. Spa Products Market - The global spa products market is poised for significant growth, with an estimated size of USD 36.44 billion by 2024. As consumers increasingly prioritize holistic self-care and premium personal care solutions, this market is expected to expand at a CAGR of 7.5% from 2025 to 2030. Spanning skin care, hair care, and body care products, the spa industry has evolved to cater to diverse needs, with offerings that can be used in spas, dermatology clinics, and even at home. Aesthetic Surgery Procedures Market - The global aesthetic surgery procedures market size is expected to reach USD 132.2 billion by 2030, according to a new report by The Research Insights. It is projected to expand at a CAGR of 12.9% from 2023 to 2030. The market has witnessed significant expansion due to a convergence of factors that cater to the growing desire for cosmetic enhancements among consumers. Professional Beauty Services Market - The global professional beauty services market size is anticipated to reach USD 395.69 Billion by 2030 and is projected to grow at a CAGR of 7.0% from 2024 to 2030, according to a new report by The Research Insights. The global professional beauty services market has witnessed significant growth in recent years, driven by shifting consumer preferences and increased disposable incomes. Thermal Springs Tourism Market - The global thermal springs tourism market size is expected to reach USD 130.78 billion by 2030, according to a new report by The Research Insights. It is projected to register a CAGR of 14.8% during the forecast period, driven by a convergence of factors that underscore the growing importance of wellness and self-care. As consumers become increasingly aware of the health benefits associated with thermal springs, demand has surged, propelled by an upward trend in wellness travel. Browse More related reports on Healthcare Market – About The Research Insights: The Research Insights provides thoroughly conducted research which is backed up by real-time statistics and data. Our experts are eager to help you with any information required under the sun. The key to our success is keeping abreast with the markets, industries, and ever-changing consumer trends that matter. Our market research professionals have in-depth knowledge and expertise across various domains that includes IT and Telecom, Emerging Technologies, Consumer Offerings, Manufacturing and Others. We are committed to reviewing the scope and procedure of the research studies that you select and provide you with an accurate guidance in order to assist you in taking the correct business decisions. Contact Us:If you have any queries about this report or if you would like further information, please contact us: Contact Person: Kaushik RoyE-mail: sales@ +1-312-313-8080Blog: Release: News: | Logo: View original content: SOURCE The Research Insights Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
Medical Spa Market Size worth $49.4 billion by 2030 with 15.13% CAGR - Exclusive Study by The Research Insights
CHICAGO, June 12, 2025 /PRNewswire/ -- The global medical spa market size is projected to be valued at USD 21.2 billion in 2024 and reach USD 49.4 billion by 2030, growing at a CAGR of 15.13% according to a new report by The Research Insights. The medical spa market has transformed beyond physical appearance enhancements to focus more on supporting complete well-being. More consumers today look for beauty solutions that merge inner health with traditional aesthetic treatments as equally important aspects. The convergence of wellness and holistic treatments within medical spa services has brought about a more comprehensive rejuvenating experience. The report runs an in-depth analysis of market trends, key players, and future opportunities. In general, the medical spa market growth of 15.13% comprises a range of service, age group, gender, service provider and geography which are expected to register strength during the coming years. For More Information and To Stay Updated on The Latest Developments in The Medical Spa Market Share, Download FREE Sample Pages: Market Overview and Growth Trajectory: Medical Spa Market Growth: According to an exhaustive report by The Research Insights, the Medical Spa Market is undergoing significant growth, driven the increasing number of medical spa customers prioritize sustainable practices and clean beauty products when making decisions about their self-care investments. This change demonstrates an enhanced understanding that personal wellness cannot be separated from planetary health. Medical spa clients demonstrate a rising demand for sustainable operations by preferring biodegradable treatment materials alongside recyclable packaging and energy-efficient devices. The medical spa industry stands to prosper as clean beauty establishes its place as a standard by combining outcome-focused treatments with ethical and eco-conscious principles which build trust and secure lasting customer dedication. Rising Demand for Non-Invasive Aesthetic Treatment in the Medical Spa Market: The medical spa market has experienced substantial growth because more people are seeking aesthetic procedures that do not involve surgery. Current consumers prefer aesthetic treatments which deliver visible outcomes while avoiding the risks and expenses of traditional surgery and its related downtime. Mainstream adoption of procedures like Botox alongside dermal fillers and non-surgical skin tightening reflects their popularity among people who aim for minimal enhancements or anti-aging effects. The impact of social media endures as influencers and celebrities publicly support aesthetic treatments and help normalize cosmetic self-care practices. Modern beauty standards are changing which leads to more individuals including both males and younger age groups seeking services from medical spas. The global medical spa market will experience sustained growth driven by non-invasive procedures as technology advances and market demand increases. For Detailed Market Insights, Visit: Partnerships with Dermatology Clinics and Wellness Centers: Strategic partnerships are becoming a critical strategy in the evolving medical spa market for service expansion and credibility building while drawing in wider customer groups. A significant trend in the industry includes medical spas working together with dermatology clinics and wellness centers. The partnership between medical spas and dermatology clinics is delivering comprehensive client experiences which focus on aesthetic enhancements alongside sustained skin health. Medical spas can deliver more sophisticated treatments under dermatologist supervision through partnerships that enable acne therapy options along with pigmentation correction and personalized anti-aging solutions. Through partnerships these spas obtain clinical validation for their services which ensures customers of the safety and effectiveness of their treatments. Dermatologists gain from spa amenities which provide enhanced comfort and satisfaction for patients along with added convenience and luxury. Medical spa market is growing quickly and competitive which makes these partnerships essential for differentiation and expansion while fulfilling the need for personalized self-care services. Facial Treatments Remain the Cornerstone of Growth in the Medical Spa Market: The medical spa market shows facial treatments as the dominant preference with the largest market share because of their flexible nature and rapid results with little downtime. Medical spa services such as hydrafacials and microdermabrasion along with laser skin resurfacing and anti-aging facials provide solutions for diverse skin problems including acne hyperpigmentation and fine lines. Facial treatments gain popularity through exposure on social media platforms and the widespread goal of achieving a youthful look that looks good on camera. Medical spas now offer advanced facial treatments that combine diagnostic tools and serums with non-invasive technologies to meet the rising demand for personalized skincare solutions. The combination of high repeat rates and multiple treatment modalities in one session enables facial treatments to both improve customer satisfaction and increase recurring revenue for providers. Facial treatments continue to function as a primary revenue engine while maintaining strategic importance in the developing medical spa landscape. Stay Updated on The Latest Medical Spa Market Trends: Geographical Insights: The medical spa market sees North America as its leader because of its robust healthcare system along with consumer awareness and dedication to personal grooming and wellness. A significant number of licensed medical spas offering advanced non-invasive treatments including Botox, laser therapy, and tailored facials exist in the United States. The medical spa market in Asia Pacific experiences the most rapid growth because of increased disposable income and urbanization along with higher acceptance of cosmetic procedures among its younger demographic. The European medical spa market merges wellness and medical aesthetics in balance while Germany, France, Italy, and the UK spearhead this initiative. Medical Spa Market Segmentation and Geographical Insights: Based on service, the medical spa market size is divided into facial treatment, body shaping & contouring, hair removal, scar revision, tattoo removal and other services. The facial treatment segment held the largest share of the medical spa market in 2024. Based on age group, the medical spa market share is divided into adolescent, adult and geriatric. The adult segment accounted for a larger share of the medical spa market in 2024. Based on gender, the medical spa market size is divided into male and female. The female segment held the largest share of the medical spa market in 2024. Based on service provider, the medical spa market share is divided into single ownership, group ownership, free-standing and medical practice associated spas. The single ownership segment accounted for a larger share of the medical spa market in 2024. The medical spa market is segmented into five major regions: North America, Europe, Asia Pacific, Central & South America and Middle East & Africa. Purchase Premium Copy of Global Medical Spa Market Size and Growth Report (2024-2030) at: Key Players and Competitive Landscape: The Medical Spa Market is characterized by the presence of several major players, including: Chic La Vie Med Spa Clinique La Prairie Kurotel-Longevity Medical Center and Spa Lanserhof The Orchard Wellness Resort Biovital Medspa LLC Allure Medspa Longevity Wellness Worldwide Serenity Medspa Vichy Celestins Spa Hotel Brenners Park-Hotel & Spa SHA Wellness Clinic Cocoona Centre Of Aesthetic Transformation Mezzatorre Hotel and Thermal SPA Aesthetics Medispa Lily's Medical Spa Lisse The DRx Clinic Westchase Medspa Chiva Som Mandarin Oriental Hotel Group Limited These companies are adopting strategies such as new product launches, joint ventures, and geographical expansion to maintain their competitive edge in the market. Global Medical Spa Market Recent Developments and Innovations: In December 2024, LaserAway, announced a strategic partnership with a global skincare brand to incorporate high-end skincare products into their treatment offerings. This collaboration allows LaserAway to offer a more comprehensive range of treatments, enhancing the overall experience for clients. In November 2023, SHA Wellness Clinic launched its first international outpost in Mexico next January. The opening will be the first step in the company's global expansion plans, followed by an Abu Dhabi location in 2025. In January 2023, Chiva Som introduced an online naturopathic and nutritional consultation program designed for children. This initiative aimed to provide specialized holistic health guidance for children, reflecting the commitment to complete wellbeing. For Region-Specific Market Data, Check Out Brief Sample Pages: Key Questions Addressed: What is the key opportunity in the medical spa market?Personalization and bundling of aesthetic treatments in subscription formats are gaining popularity, ensuring customer retention and recurring revenue. What is the expected market size for medical spa market by 2030? The expected market size for medical spa is USD 49.4 Billion in 2030. Which major service are included in medical spa?Major service includes facial treatment, body shaping & contouring, hair removal, scar revision, tattoo removal and other services. Which service provider segment for medical spa market has the potential to register the highest market share? Single ownership segment for medical spa market is expected to register highest market share of 37% in 2024. Who are the key players in medical spa market?The key players in the market are Chic La Vie Med Spa, Clinique La Prairie, Kurotel-Longevity Medical Center and Spa, Lanserhof, The Orchard Wellness Resort, Biovital Medspa LLC, Allure Medspa, Longevity Wellness Worldwide, Serenity Medspa, Vichy Celestins Spa Hotel, Brenners Park-Hotel & Spa, SHA Wellness Clinic, Cocoona Centre Of Aesthetic Transformation, Mezzatorre Hotel & Thermal SPA, Aesthetics Medispa, Lily's Medical Spa, Lisse, The DRx Clinic, Westchase Medspa, Chiva Som and Mandarin Oriental Hotel Group Limited. Conclusion: The medical spa market is experiencing transformative changes because clinical expertise and holistic wellness converge as consumers demand treatments that boost physical appearance while promoting total health. Facial treatments remain the primary source of income for medical spas because their wide-reaching skin benefits deliver quick results and easy accessibility for clients. Technology-enabled personalized skincare solutions which incorporate AI diagnostics and custom treatments are resulting in increased client loyalty and satisfaction. Despite continuing regulatory hurdles and competition along with expensive advanced equipment the medical spa industry remains resilient because of innovation and growing demand for minimally invasive procedures and comprehensive care approaches. The medical spa market continues to develop as a vibrant sector that successfully addresses today's consumers' needs for both beauty and health solutions while promoting mindful self-care which supports its long-term worldwide expansion. Need A Diverse Region or Sector? Customize Research to Suit Your Requirement: The report from The Research Insights, therefore, provides several stakeholders—including raw material & equipment suppliers, product manufacturers, service providers, and medical professionals—with valuable insights into how to successfully navigate this evolving market landscape and unlock new opportunities. With projected growth to US$ 49.4 billion by 2030, the Medical Spa Market represents a significant opportunity for raw material & equipment suppliers, product manufacturers, service providers, and medical professionals, investors, industry stakeholders, and others. By staying abreast of market trends, embracing innovation, and focusing on quality and performance, companies can position themselves for success in this dynamic and evolving market landscape. Check out more related studies published by The Research Insights: U.S. Medical Spa Management Software Market - The U.S. medical spa management software market is poised for significant growth, with an estimated value of USD 118.1 million in 2023. As the industry continues to expand at a CAGR of 13.6% from 2024 to 2030, it's clear that these facilities are becoming increasingly popular due to their unique blend of wellness and beauty services. By offering a wide range of cosmetic treatments and procedures in a relaxing spa-like environment, medical spas have captured the hearts (and wallets) of consumers seeking a more holistic approach to their self-care routines. Spa Products Market - The global spa products market is poised for significant growth, with an estimated size of USD 36.44 billion by 2024. As consumers increasingly prioritize holistic self-care and premium personal care solutions, this market is expected to expand at a CAGR of 7.5% from 2025 to 2030. Spanning skin care, hair care, and body care products, the spa industry has evolved to cater to diverse needs, with offerings that can be used in spas, dermatology clinics, and even at home. Aesthetic Surgery Procedures Market - The global aesthetic surgery procedures market size is expected to reach USD 132.2 billion by 2030, according to a new report by The Research Insights. It is projected to expand at a CAGR of 12.9% from 2023 to 2030. The market has witnessed significant expansion due to a convergence of factors that cater to the growing desire for cosmetic enhancements among consumers. Professional Beauty Services Market - The global professional beauty services market size is anticipated to reach USD 395.69 Billion by 2030 and is projected to grow at a CAGR of 7.0% from 2024 to 2030, according to a new report by The Research Insights. The global professional beauty services market has witnessed significant growth in recent years, driven by shifting consumer preferences and increased disposable incomes. Thermal Springs Tourism Market - The global thermal springs tourism market size is expected to reach USD 130.78 billion by 2030, according to a new report by The Research Insights. It is projected to register a CAGR of 14.8% during the forecast period, driven by a convergence of factors that underscore the growing importance of wellness and self-care. As consumers become increasingly aware of the health benefits associated with thermal springs, demand has surged, propelled by an upward trend in wellness travel. Browse More related reports on Healthcare Market – About The Research Insights: The Research Insights provides thoroughly conducted research which is backed up by real-time statistics and data. Our experts are eager to help you with any information required under the sun. The key to our success is keeping abreast with the markets, industries, and ever-changing consumer trends that matter. Our market research professionals have in-depth knowledge and expertise across various domains that includes IT and Telecom, Emerging Technologies, Consumer Offerings, Manufacturing and Others. We are committed to reviewing the scope and procedure of the research studies that you select and provide you with an accurate guidance in order to assist you in taking the correct business decisions. Contact Us:If you have any queries about this report or if you would like further information, please contact us: Contact Person: Kaushik RoyE-mail: sales@ +1-312-313-8080Blog: Release: News: | Logo: View original content: SOURCE The Research Insights
